Retiring, Rethinking, and Reconstructing the Norm of Once-Weekly Psychotherapy.

"Conflict of interest JLS receives grant and research support from the National Institutes of Health (DP5OD28123), the Klingenstein Third Generation Foundation, the American Psychological Foundation, the National Science Foundation, and Limbix, Inc. MLD receives research funding from the Psi Chi Honor Society. JLS, MLD, and MCM have co-written a forthcoming therapeutic workbook for adolescents, to be published by New Harbinger Publications. JLS is under contract with Oxford University Press to co-edit a book on low-intensity youth mental health interventions. JLS serves on the scientific advisory board for Walden Wise. The authors report no other financial conflicts."

"Compliance with the Ethical Standards: Conflict of interestJLS receives grant and research support from the National Institutes of Health (DP5OD28123), the Klingenstein Third Generation Foundation, the American Psychological Foundation, the National Science Foundation, and Limbix, Inc. MLD receives research funding from the Psi Chi Honor Society. JLS, MLD, and MCM have co-written a forthcoming therapeutic workbook for adolescents, to be published by New Harbinger Publications. JLS is under contract with Oxford University Press to co-edit a book on low-intensity youth mental health interventions. JLS serves on the scientific advisory board for Walden Wise. The authors report no other financial conflicts. Conflict of interest: JLS receives grant and research support from the National Institutes of Health (DP5OD28123), the Klingenstein Third Generation Foundation, the American Psychological Foundation, the National Science Foundation, and Limbix, Inc. MLD receives research funding from the Psi Chi Honor Society. JLS, MLD, and MCM have co-written a forthcoming therapeutic workbook for adolescents, to be published by New Harbinger Publications. JLS is under contract with Oxford University Press to co-edit a book on low-intensity youth mental health interventions. JLS serves on the scientific advisory board for Walden Wise. The authors report no other financial conflicts."